Login to Your Account


Beantown boom goes on; pharma promises candid stance, early stage deals

By Randy Osborne
Staff Writer

Wednesday, September 24, 2014
BOSTON – The head of Pfizer Inc.'s Center for Therapeutic Innovation (CTI) called Boston "a wildly synergistic hotbed" for new ideas, during a panel on the final day of EBD Group's BioPharm America, designed to hook up would-be partners for talks around drug development deals.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription